Document is current
Any future updates will be listed below
-
Authors
Tevonian, Erin N. https://orcid.org/0000-0001-7645-1957
Kan, Ellen L. https://orcid.org/0009-0001-3125-2492
Maniar, Kairav K. https://orcid.org/0000-0002-6566-5017
Wang, Alex J.
Datta, Anisha
Kamm, Roger D. https://orcid.org/0000-0002-7232-304X
Lauffenburger, Douglas A. https://orcid.org/0000-0002-0050-989X
Griffith, Linda G. https://orcid.org/0000-0002-1801-5548
-
Funding
Funding for this research was provided by:
Novo Nordisk
Massachusetts Life Sciences Center (6945983, 6947253, 6946296)
- License Information
-
More Information
Article History
Received: 20 January 2025
Accepted: 12 December 2025
First Online: 3 February 2026
Competing interests
: R.D.K is a co-founder of AIM Biotech, a company that markets microfluidic technologies. The other authors declare no competing interests.
